References
Begaud B, Evreux J, Jouglard J, Lagier G. Unexpected or toxic drug reaction assessment (Imputation). Actualization of the method used in France. Thérapie 40: 111–118, 1985
Bello-Reuss E, Higashi Y, Kaneda Y. Dopamine decrease fluid reabsorption in straight portions of rabbit proximal tubule. American Journal of Physiology 242: 634–640, 1982
Bogaert M, Buylaert W, Lefebvre R, Willems J. Récepteurs dopaminergiques périphériques. Actualités Pharmacologiques 33: 57–75, 1980
Damase-Michel C, Montastruc JL, Tran MA, Gharib C, Geelen G, et al. Involvement of vasopressin in the cardiovascular effects of quinpirole. European Journal of Pharmacology 184: 179–183, 1990
Horrobin DF. Prolactin as a regulator of fluid and electrolyte metabolism in mammals. Federation Proceedings 39: 2567–2570, 1980
Lokhandwala MF, Hedge SS. Cardiovascular dopamine receptors: Role of renal dopamine and dopamine receptors in sodium excretion. Pharmacology and Toxicology 66: 237–243, 1990
Marschall AW, Jakobovits AW, Morgan MY. Bromocriptine-associated hyponatraemia in cirrhosis. British Medical Journal 285: 1534, 1982
McDonald RH, Goldberg LI, McNay JL, Tuttle EP. Effects of dopamine in man: augmentation of sodium excretion, glomerular filtration rate and renal plasma flow. Journal of Clinical Investigation 43: 1116, 1964
Montastruc JL, Montastruc P. Alpha-adrenolytic properties of bromocriptine. Archives Internationales de Pharmacodynamie et de Therapie 260: 83–90, 1982
Moses A, Miller M. Drug induced dilutional hyponatremia. New England Journal of Medicine 5: 1234–1239, 1974
Nagahama S, Ann HS, Chen Y, Linheimer MD, Oparil S. Role of vasopressin in the cardiovascular effects of LY 171555, a selective D2 receptor agonist; studies in conscious Brattleboro and Long-Evans rats. Journal of Pharmacological and Experimental Therapeutics 242: 143, 1987
Pettinger WA, Umemura S, Smyth D, Jeffries W. Renal α2-adrenoceptors and the adenylate cyclase-cAMP system: biochemical and physiological interactions. American Journal of Physiology 252: 199–208, 1987
Robinson EG, Clifton-Bligh P, Posen S, Morris BJ. The effect of bromocriptine on circulating vasopressin. Clinical Science 63: 367–372, 1982
Seri I. Dopamine and natriuresis mechanism of action and developmental aspects. American Journal of Hypertension 3: 82–86, 1990
Smyth D, Pettinger WA, Umemura S. Renal nerve stimulation causes α1-adrenoceptor mediated sodium retention but no α2-adrenoceptor antagonism of vasopressin. Circulation Research 57: 304–311, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Damase-Michel, C., Sarrail, E., Laens, J. et al. Hyponatraemia in a Patient Treated with Bromocriptine. Drug Invest. 5, 285–287 (1993). https://doi.org/10.1007/BF03259594
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03259594